Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oculocutaneous albinism II protein (OCA2), also known as P protein or pink-eyed dilution protein homolog, is an integral membrane protein predominantly found in the melanosomal membrane of pigment-producing cells (melanocytes) and the retinal pigment epithelium[1][2][3][5]. OCA2 is predicted to function as a transporter—possibly a Na^+/dicarboxylate symporter or as part of a chloride channel—regulating the ionic environment and pH inside melanosomes to optimize melanin biosynthesis[1][3]. Defects or genetic mutations in OCA2 cause type II oculocutaneous albinism, the most common form of genetically inherited albinism, by impairing melanosome maturation, reducing melanin content, and leading to hypopigmentation of the skin, hair, and eyes as well as vision problems[1][3][4][5]. The protein contains twelve transmembrane helices and functions in the trafficking of other melanosomal proteins, likely through dileucine-based cytoplasmic motifs important for targeting to melanosomes and/or lysosomes[1][2][4]. OCA2 is not a primary therapeutic target nor does it have drugs known to directly interact with it, but mutation testing is a key diagnostic and prognostic biomarker in relevant pigmentation disorders[5].
Not targeted by therapeutic drugs; Genetic mutations affect pigment biosynthesis by disrupting ion transport/chloride conductance[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oculocutaneous albinism II protein (OCA2).